Antibody Production and ELISA Development


Starting with immunogen or epitope sequence information, through purification and characterization of a therapeutic or diagnostic antibody, CBI can support drug and diagnostic development organizations from discovery to market. GLP and CLIA compliance with BSL-3 facilities.

View a printable PDF of this page

Please select a technology to find out more about our immunology services:


Immunogen / Epitope Preparation and Characterization

Immunogen / Epitope Preparation and CharacterizationEpitope analysis and prediction of immunogenic peptide sequences
MAPS (4 or 8 arm peptide sequences)
Fully automated and manual preparation of immunogenic peptides
Conjugation of immunogens to carrier proteins
[return to top]

Monoclonal Antibodies

Hybridoma development
Immunization and screening
Fusion and screening of hybridomas
Cloning and ascites productions
In Vivo monoclonal production
In Vitro monoclonal production
Purification of IgGs, IgMs, IgYs
[return to top]

Polyclonal Antisera

Immunization with supplied material or immunogens prepared by CBI
Purification by large scale protein A or L, differential precipitation, DEAE chromatography or gel filtration chromatography
[return to top]

Monospecific Polyclonal Antisera

Immobilization of antigen to column matrix or synthesized to antigen synthesized directly to column resin de novo
Purification by peptide affinity ligand chromatography
[return to top]

Antibody Structural Characterization

Analysis with intact IgG and subsequent mass spectral analysis and amino acid analysis
Chain separation by SDS-Page
Direct N-terminal sequence analysis of separated heavy chain and light chain
Peptide mapping of heavy and light chains by chromatographic or mass spectral analysis
Primary sequence determination by digestion and mass spectroscopy
Ligand binding studies by isothermal titration calorimetry (ITC)
Thermal stability by differential scanning calorimetry (DSC)
[return to top]

Labeled Antibodies

Custom labeling with biotin, HRP, AP, FITC, etc.
ELISA determination of titers
[return to top]

ELISA Development

Direct, indirect, and sandwich ELISA protocols
Ligand supplied or developed at CBI
Assay validation protocols
[return to top]

  Products & Services
  Order Forms
Quote / Information Request

Contact:


Worldwide
Commonwealth Biotechnologies, Inc.
601 Biotech Drive
Richmond, VA 23235
[email protected]
Toll Free: 800-RELY-CBI
(800-735-9224)

Telephone: (804) 648-3820

Fax: (804) 648-2641

In India contact:


Link Biotech, www.linkbiotech.co.in
New Delhi, India is the exclusice distributor of CBI's biotechnology-related goods, products, and services in the Northern India regions of the Punjab, Utter Pradesh, Jammu, and Kashmir, Uttranchal, Uttrankhand, Haryna, Madhya Pradesh, and Rajasthan.
Link Biotech provides quality research and development support services to Pharmaceutical, Biotechnology and Agri-Biotech companies.